Lizhi Zhang

Lizhi Zhang, M.D. is a board-certified pathologist and Professor of Pathology at Mayo Clinic School of Medicine in Rochester, Minnesota. He is affiliated with the Department of Laboratory Medicine and Pathology, specializing in Anatomic Pathology with a focus on gastrointestinal, liver, and pancreatic diseases.

Dr. Zhang's educational background includes:

• M.D. from Dalian Medical College (1993)
• Master of Science in Surgery from Dalian Medical University Graduate School (1996)
• Postdoctoral Research Fellowship at Universitat Bern (1998)
• Postdoctoral Research Fellowship at University of Michigan Medical School (2004)
• Residency in Anatomic and Clinical Pathology at Mayo Clinic (2008)
• Fellowship in Gastroenterology/Liver Pathology at Mayo Clinic (2009)

Dr. Zhang's research primarily focuses on pancreatic pathology, with special emphasis on pancreatic cancer, pancreatic neuroendocrine tumors, and autoimmune pancreatitis. His work integrates clinical, molecular, and genomic approaches to advance translational understanding of pancreatic diseases. His research portfolio demonstrates a consistent trajectory in hepatobiliary and pancreatic pathology, with particular expertise in IgG4-related diseases and cholangiocarcinoma. Over his career, he has developed significant expertise in using histopathological and immunohistochemical techniques to identify prognostic markers in gastrointestinal malignancies.

Dr. Zhang has received numerous scientific awards including:

• Stowell-Orbison Award from United States and Canadian Academy of Pathology (2009)
• Rodger C. Haggitt Gastrointestinal Pathology Society Award (2006)
• Research Travel Award from American Pancreatic Association (1999)
• Multiple Science and Technique Progress Awards from LiaoNing Province (1997-1998)
• Scholarship for Outstanding Medical Students from Dalian Medical University (1988)

Throughout his career, Dr. Zhang has held significant leadership positions including serving as President of The International Association of Chinese Pathologists (2014-2015) and as Co-Director of Tissue Core for Mayo Clinic SPORE in Pancreatic Cancer since 2009. He has been an active member of numerous professional organizations including the American Society for Clinical Pathology, Rodger C. Haggitt Gastrointestinal Pathology Society, College of American Pathologists, and United States and Canadian Academy of Pathology.

Dr. Zhang contributes to pancreatic cancer research through his role with the Mayo Clinic Cancer Center, where he has served on the Scientific Review Committee and as a member of the Research Committee for the Division of Anatomic Pathology. His work has significantly advanced the understanding of molecular markers in pancreatic and hepatobiliary diseases.